OXYBUTYNIN CHLORIDE Recall D-0038-2024
Description: Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 68382-256-01) and b) 500 tablets (NDC 68382-256-05) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534
OXYBUTYNIN CHLORIDE Recall D-0038-2024 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0038-2024 |
| Event ID | 93100 |
| Brand | OXYBUTYNIN |
| Generic Name | OXYBUTYNIN |
| Manufacturer | OXYBUTYNIN |
| Original Package? | 1 |
| Active Substance | OXYBUTYNIN CHLORIDE |
| Drug Route | ORAL |
| Distribution | Nationwide in the USA. |
| Quantity | 7,248 bottles |
| Recall Reason | Failed Dissolution Specifications |
| Drug Classification | Class II |
| Drug Code Info | 20231011 |
| Product NDC | 68382-255 68382-256 68382-257 |
| Drug UPC | 0368382256010 |
| Recall Initiation Date | 20230921 |
| Report Date | 20231011 |
| Classification Date | 20231004 |
| Address | 73 Route 31 N Pennington, NJ 08534-3601 United States |
| Recalling Firm | Zydus Pharmaceuticals (USA) Inc |
| Initial Notification | Letter |
| Unique Ingredient Identifier | L9F3D9RENQ |
| Drug Application Number | ANDA202332 |
| Structured Product Labeling (SPL ID) | 08f2f8b4-0532-471c-bcb8-d0023104e3f4 |
| Structured Product Labeling (SPL Set ID) | c042bf06-79a3-4dc7-ae05-3ef3cfae9d44 |
| Similar To |